Harvard Business Review

MARCH 18, 2018

In fact, by government edict, the goal is to direct policy, health care, and even citizens themselves toward longer, healthier, more enriching lives. Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. By country, Japan had 9.1

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. So reducing investments in low-value care services means spending less on doctors, hospitals, and other health care technologies. rawpixel/Getty Images.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MARCH 12, 2012

His company is quite respected in the sustainability community both for its progressive social equity policies and for green technology that limits the environmental impacts of his company's manufacturing activities. So I asked: Do you foresee a time when you'd willingly provide access to your leading green technology to your competitors?

Co-Opetition 13

Co-Opetition Company Brandenburger Game Theory 13

Harvard Business Review

MAY 1, 2013

While currently crippled by inadequate infrastructure in many countries, low- and middle-income countries will be the fastest-growing markets for pharmaceuticals and medical devices over the next decade. What can the health care industry do to help fight disease, while still maintaining its commitments to shareholders? Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. But in the era of Big Data and decision-making at the desktop, it's vexing to think that any company with significant technology investments would allow the all-too-human traits of ownership debates and subjective opinion to override robust data analysis.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

JUNE 22, 2016

But all assets are not created equal, especially as the technological landscape changes. In today’s market, tech platforms enable IP and relationships to scale rapidly, and at near-zero cost. Even when these firms rely on physical assets, like cars for Uber, they own the technology, not the physical asset.

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

SEPTEMBER 14, 2017

The belief is that at-risk pay motivates salespeople to work hard and direct effort towards sales activities that encourage achievement of sales goals. One technology company targeted a 50:50 pay mix for salespeople in new customer acquisition (CA) roles, but a 70:30 mix for salespeople in account management (AM) roles.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Another problem we’ve seen is that some providers, seeking to fit in to a payment cycle, focus on short-term results, losing sight of the end goals. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 13, 2011

You either achieve your goals or you don't. Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago. Most organizations take the same stance.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Corporate R&D too often focuses on refining technologies that are already in use. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water? It''s like that.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Corporate R&D too often focuses on refining technologies that are already in use. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water? Ready to Innovate?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

NOVEMBER 24, 2015

Mergers in the beer industry have been driven not by production economies (efficient beer plants are relatively small), but by the benefits of scale in marketing and distribution. This kind of joint value is more common in computers and industrial products than in pharmaceuticals.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. The negotiators achieved their goal and closed a clever and profitable deal. PDF) But that would leave you out of the game for many new technologies and markets, where alliances are essential.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

AUGUST 29, 2011

We discovered some of these pushes and pulls in our research for our upcoming book, Winning the War for Talent in Emerging Markets: Why Women Are the Solution. Women are critical contributors in finance, info-tech, pharmaceutical research, and other industries that are driving the growth of India Inc. We do all of them.".

Stress 14

Stress Human Resources Pharmaceuticals Sharpe 14

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

DECEMBER 27, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). In it, he traces the intersection of science and marketing that''s made junk food so delicious, so profitable, and so very bad for you.

Armstrong 8

Armstrong Long-term Short-term CEO 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

JUNE 12, 2018

The pervasive adoption of mobile devices has driven an explosion of contextual user information, including geolocation data, which has become a valuable resource for marketers. However, a lack of technical skill sets among marketers has made it difficult for them to use this data (when they have access to it) effectively.

Short-term 8

Short-term Brand Long-term Media 8

Harvard Business Review

DECEMBER 12, 2018

A new generation of philanthropists, whose wealth was created via entrepreneurship in technology-driven fields, has the unique opportunity to make a real difference in speeding the pace of progress in the fight against cancer. And new approaches to philanthropy, often termed impact investing , have emerged as a path to meet their goals.

Pharmaceuticals 8

Pharmaceuticals Venture Funding Finance Development 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. Sponsored by DXC Technology.

Innovation 13

Innovation Productivity Products Venture Capitalist 13